Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1.

Pathol Oncol Res. 2000;6(1):27-37. Unique Identifier : AIDSLINE MED/20213656
Ongradi J; Laird HM; Szilagyi JF; Horvath A; Bendinelli M; National Institute of Dermato-Venerology Maria utca 41.,; Budapest, 1085, Hungary. ongjos@hotmail.com


Abstract: C8166 cells express T lymphocyte markers, a monocyte-specific esterase, taxpolypeptide of HTLV-I. In spite of this transactivator, their HIV-1 yield is low. Their culture conditions were modified, and infected cells were immobilized on a poly-L-lysine sheet under semisolid overlays to study their phenotypic alterations and HIV-1 production by microscopy and electron microscopy. Another lymphoid cultures (MT-4, CEM, CEM-ss, AdCEM) similarly treated were infected with either HIV-1/RF or IIIB. Specificity of HIV-1 was compared to the effects of vesicular stomatitis virus (VSV). Unlike other cultures, HIV-1/RF infected C8166 cells in Eagle s MEM exhibited surface projections resembling hairy leukemia cells, which was followed by balloon degeneration and apoptosis. Immobilized HIV-1 infected cultures formed flat syncytia with several interdigitating dendritic projections. Syncytia shrunk with condensed nuclear material and axon-like filaments characteristic for infected macrophages. VSV induced enlargement and necrotic lysis of all cell types. Early postinfection with HIV-1, electron microscopy revealed irreversible membrane fusion above cell nuclei, and transient fusion between filaments. Transient presence of coated vesicles containing intact HIV-1 particles, Birbeck granule-like structures of Langerhans cells, fibrillar-lamellar structures resembling hairy leukemia or Sezary cells were detected. Late postinfection, high proportion of HIV-1 bud from polarized cytoplasm was empty particle, while that bud and entrapped in cytoplasmic vacuoles contained two or multiple cores in a fused envelope. The effect of early gene products of HIV-1 on HTLV-I and C8166 cells might elicit their latent potentials for monocyte or interdigitating dendritic cells, while in the later phase HTLV-I products might alter HIV-1 virion assembly.
Keywords: JOURNAL ARTICLE Apoptosis Calcium/PHARMACOLOGY Cell Line *Cell Transformation, Viral Cytopathogenic Effect, Viral Giant Cells/ULTRASTRUCTURE Human HIV-1/*PHYSIOLOGY HTLV-I/*PHYSIOLOGY Membrane Fusion Microscopy, Electron Microvilli/ULTRASTRUCTURE Phenotype Proviruses/PHYSIOLOGY Support, Non-U.S. Gov't T-Lymphocytes/DRUG EFFECTS/PATHOLOGY/*VIROLOGY Vacuoles/ULTRASTRUCTURE Vesicular Stomatitis-Indiana Virus/PHYSIOLOGYKWDjournalarticleapoptosiscalcium/pharmacologycelllineKWDcelltransformation,viralcytopathogeniceffect,viralgiantcells/ultrastructurehumanhiv-1/KWDphysiologyhtlv-i/KWDphysiologymembranefusionmicroscopy,electronmicrovilli/ultrastructurephenotypeproviruses/physiologysupport,non-uKWDsKWDgov'tt-lymphocytes/drugeffects/pathology/KWDvirologyvacuoles/ultrastructurevesicularstomatitis-indianavirus/physiology
001030
A00A1076

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .